bisindolylmaleimide i has been researched along with Lymphoma, B-Cell in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romanova, LY | 1 |
| Alexandrov, IA | 1 |
| Nordan, RP | 1 |
| Blagosklonny, MV | 1 |
| Mushinski, JF | 1 |
1 other study available for bisindolylmaleimide i and Lymphoma, B-Cell
| Article | Year |
|---|---|
Cross-talk between protein kinase C-alpha (PKC-alpha) and -delta (PKC-delta): PKC-alpha elevates the PKC-delta protein level, altering its mRNA transcription and degradation.
Topics: Animals; Enzyme Activation; Enzyme Stability; Indoles; Isoenzymes; Leukemia, Promyelocytic, Acute; L | 1998 |